Novartis AG (NOVN.SW)
CHF 88.04
(-0.77%)
CHF 88.04
(-0.77%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 26.34 Billion USD | -5.78% |
| 2022 | 27.96 Billion USD | -10.06% |
| 2021 | 31.09 Billion USD | -18.28% |
| 2020 | 38.04 Billion USD | 29.71% |
| 2019 | 29.33 Billion USD | -8.59% |
| 2018 | 32.09 Billion USD | 12.89% |
| 2017 | 28.42 Billion USD | 19.42% |
| 2016 | 23.8 Billion USD | 8.53% |
| 2015 | 21.93 Billion USD | 7.45% |
| 2014 | 20.41 Billion USD | 13.28% |
| 2013 | 18.01 Billion USD | -8.66% |
| 2012 | 19.72 Billion USD | -2.34% |
| 2011 | 20.19 Billion USD | -11.96% |
| 2010 | 22.94 Billion USD | 64.96% |
| 2009 | 13.9 Billion USD | 97.7% |
| 2008 | 7.03 Billion USD | 25.78% |
| 2007 | 5.59 Billion USD | -22.49% |
| 2006 | 7.21 Billion USD | -12.1% |
| 2005 | 8.2 Billion USD | 25.18% |
| 2004 | 6.55 Billion USD | 19.87% |
| 2003 | 5.47 Billion USD | -2.04% |
| 2002 | 5.58 Billion USD | 22.32% |
| 2001 | 4.56 Billion USD | 23.54% |
| 2000 | 3.69 Billion USD | -40.78% |
| 1999 | 6.24 Billion USD | 0.09% |
| 1998 | 6.23 Billion USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 28.98 Billion USD | 6.24% |
| 2024 Q3 | 30.31 Billion USD | 10.94% |
| 2024 Q1 | 27.28 Billion USD | 3.55% |
| 2023 FY | 26.34 Billion USD | -5.78% |
| 2023 Q4 | 26.34 Billion USD | 4.6% |
| 2023 Q3 | 25.18 Billion USD | -11.12% |
| 2023 Q1 | 29.2 Billion USD | 4.43% |
| 2023 Q2 | 28.34 Billion USD | -2.96% |
| 2022 Q3 | 28.53 Billion USD | -8.2% |
| 2022 Q4 | 27.96 Billion USD | -2.01% |
| 2022 FY | 27.96 Billion USD | -10.06% |
| 2022 Q1 | 31.34 Billion USD | 0.8% |
| 2022 Q2 | 31.08 Billion USD | -0.81% |
| 2021 Q1 | 37.84 Billion USD | -0.54% |
| 2021 Q2 | 35.84 Billion USD | -5.28% |
| 2021 FY | 31.09 Billion USD | -18.28% |
| 2021 Q3 | 34.32 Billion USD | -4.23% |
| 2021 Q4 | 31.09 Billion USD | -9.43% |
| 2020 Q2 | 34.78 Billion USD | -5.2% |
| 2020 Q3 | 38.17 Billion USD | 9.74% |
| 2020 Q4 | 38.04 Billion USD | -0.33% |
| 2020 Q1 | 36.69 Billion USD | 25.1% |
| 2020 FY | 38.04 Billion USD | 29.71% |
| 2019 Q4 | 29.33 Billion USD | -2.6% |
| 2019 Q1 | 30.59 Billion USD | -4.67% |
| 2019 FY | 29.33 Billion USD | -8.59% |
| 2019 Q2 | 30.26 Billion USD | -1.06% |
| 2019 Q3 | 30.11 Billion USD | -0.5% |
| 2018 Q1 | 34.11 Billion USD | 20.0% |
| 2018 Q4 | 32.09 Billion USD | 0.97% |
| 2018 FY | 32.09 Billion USD | 12.89% |
| 2018 Q3 | 31.78 Billion USD | -1.77% |
| 2018 Q2 | 32.35 Billion USD | -5.14% |
| 2017 Q3 | 30.16 Billion USD | -1.31% |
| 2017 Q2 | 30.56 Billion USD | -2.23% |
| 2017 Q1 | 31.25 Billion USD | 31.32% |
| 2017 Q4 | 28.42 Billion USD | -5.75% |
| 2017 FY | 28.42 Billion USD | 19.42% |
| 2016 FY | 23.8 Billion USD | 8.53% |
| 2016 Q3 | 26.56 Billion USD | 0.75% |
| 2016 Q2 | 26.36 Billion USD | -6.14% |
| 2016 Q1 | 28.09 Billion USD | 28.1% |
| 2016 Q4 | 23.8 Billion USD | -10.4% |
| 2015 Q2 | 23.27 Billion USD | -7.32% |
| 2015 FY | 21.93 Billion USD | 7.45% |
| 2015 Q1 | 25.11 Billion USD | 23.04% |
| 2015 Q3 | 22.7 Billion USD | -2.46% |
| 2015 Q4 | 21.93 Billion USD | -3.39% |
| 2014 Q1 | 21.21 Billion USD | 17.72% |
| 2014 FY | 20.41 Billion USD | 13.28% |
| 2014 Q4 | 20.41 Billion USD | 4.1% |
| 2014 Q2 | 20.43 Billion USD | -3.68% |
| 2014 Q3 | 19.6 Billion USD | -4.03% |
| 2013 Q1 | 20.94 Billion USD | 6.17% |
| 2013 FY | 18.01 Billion USD | -8.66% |
| 2013 Q4 | 18.01 Billion USD | -4.03% |
| 2013 Q3 | 18.77 Billion USD | -0.51% |
| 2013 Q2 | 18.87 Billion USD | -9.9% |
| 2012 Q4 | 19.72 Billion USD | -5.35% |
| 2012 Q1 | 24.59 Billion USD | 21.76% |
| 2012 Q2 | 22.63 Billion USD | -7.98% |
| 2012 Q3 | 20.84 Billion USD | -7.92% |
| 2012 FY | 19.72 Billion USD | -2.34% |
| 2011 Q1 | 31.11 Billion USD | 35.61% |
| 2011 FY | 20.19 Billion USD | -11.96% |
| 2011 Q4 | 20.19 Billion USD | -15.46% |
| 2011 Q3 | 23.89 Billion USD | -13.14% |
| 2011 Q2 | 27.5 Billion USD | -11.6% |
| 2010 FY | 22.94 Billion USD | 64.96% |
| 2010 Q3 | 26.96 Billion USD | 44.62% |
| 2010 Q4 | 22.94 Billion USD | -14.91% |
| 2010 Q1 | 17.92 Billion USD | 28.91% |
| 2010 Q2 | 18.64 Billion USD | 3.98% |
| 2009 Q4 | 13.9 Billion USD | -3.19% |
| 2009 FY | 13.9 Billion USD | 97.7% |
| 2009 Q1 | 11.45 Billion USD | 62.79% |
| 2009 Q2 | 13.86 Billion USD | 21.11% |
| 2009 Q3 | 14.36 Billion USD | 3.58% |
| 2008 Q1 | 6.47 Billion USD | 15.84% |
| 2008 Q4 | 7.03 Billion USD | -34.89% |
| 2008 FY | 7.03 Billion USD | 25.78% |
| 2008 Q2 | 10.73 Billion USD | 65.63% |
| 2008 Q3 | 10.8 Billion USD | 0.68% |
| 2007 Q2 | 7.45 Billion USD | 1.37% |
| 2007 FY | 5.59 Billion USD | -22.49% |
| 2007 Q1 | 7.35 Billion USD | 1.86% |
| 2007 Q4 | 5.59 Billion USD | -22.78% |
| 2007 Q3 | 7.24 Billion USD | -2.79% |
| 2006 Q3 | 9.22 Billion USD | -2.17% |
| 2006 FY | 7.21 Billion USD | -12.1% |
| 2006 Q1 | 8.09 Billion USD | -1.4% |
| 2006 Q4 | 7.21 Billion USD | -21.74% |
| 2006 Q2 | 9.42 Billion USD | 16.46% |
| 2005 FY | 8.2 Billion USD | 25.18% |
| 2005 Q4 | 8.2 Billion USD | 18.94% |
| 2005 Q2 | 7.69 Billion USD | 27.24% |
| 2005 Q1 | 6.04 Billion USD | -7.79% |
| 2005 Q3 | 6.9 Billion USD | -10.29% |
| 2004 FY | 6.55 Billion USD | 19.87% |
| 2004 Q4 | 6.55 Billion USD | 18.57% |
| 2004 Q3 | 5.53 Billion USD | -7.63% |
| 2004 Q2 | 5.98 Billion USD | -8.5% |
| 2004 Q1 | 6.54 Billion USD | 19.61% |
| 2003 Q4 | 5.47 Billion USD | -2.72% |
| 2003 FY | 5.47 Billion USD | -2.04% |
| 2003 Q2 | 6.97 Billion USD | 18.56% |
| 2003 Q1 | 5.87 Billion USD | 5.26% |
| 2003 Q3 | 5.62 Billion USD | -19.31% |
| 2002 Q2 | 5.04 Billion USD | 0.0% |
| 2002 Q4 | 5.58 Billion USD | 13.63% |
| 2002 Q3 | 4.91 Billion USD | -2.65% |
| 2002 FY | 5.58 Billion USD | 22.32% |
| 2001 Q2 | 4.32 Billion USD | 0.0% |
| 2001 FY | 4.56 Billion USD | 23.54% |
| 2001 Q4 | 4.56 Billion USD | 0.0% |
| 2000 Q4 | 3.69 Billion USD | 0.0% |
| 2000 Q2 | 5.09 Billion USD | 0.0% |
| 2000 FY | 3.69 Billion USD | -40.78% |
| 1999 FY | 6.24 Billion USD | 0.09% |
| 1998 FY | 6.23 Billion USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Roche Holding AG | 30.78 Billion CHF | 14.405% |
| Roche Holding AG | 30.78 Billion CHF | 14.405% |